Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $92.6 million.

  • Healthstream's Cash & Current Investments fell 242.59% to $92.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.6 million, marking a year-over-year decrease of 242.59%. This contributed to the annual value of $97.2 million for FY2024, which is 3666.93% up from last year.
  • Per Healthstream's latest filing, its Cash & Current Investments stood at $92.6 million for Q3 2025, which was down 242.59% from $90.6 million recorded in Q2 2025.
  • Healthstream's 5-year Cash & Current Investments high stood at $113.3 million for Q1 2025, and its period low was $39.2 million during Q2 2022.
  • For the 5-year period, Healthstream's Cash & Current Investments averaged around $69.8 million, with its median value being $60.6 million (2021).
  • Per our database at Business Quant, Healthstream's Cash & Current Investments crashed by 6184.62% in 2021 and then soared by 4831.23% in 2024.
  • Quarter analysis of 5 years shows Healthstream's Cash & Current Investments stood at $51.9 million in 2021, then increased by 3.78% to $53.9 million in 2022, then skyrocketed by 31.95% to $71.1 million in 2023, then soared by 36.67% to $97.2 million in 2024, then fell by 4.76% to $92.6 million in 2025.
  • Its last three reported values are $92.6 million in Q3 2025, $90.6 million for Q2 2025, and $113.3 million during Q1 2025.